New Blood Test Detects Multiple Cancers and Diseases

A new blood test has been developed that analyzes DNA methylation patterns in cell-free DNA to detect multiple cancers and other diseases. The test achieved an overall cancer detection rate of approximately 63% and 55% for early-stage cancers, maintaining 98% specificity.

This method significantly reduces sequencing requirements by filtering out background DNA, leading to an estimated cost of under $20 per sample. The test also demonstrated the ability to identify the likely tissue of origin for detected diseases.

In high-risk liver cancer patients, the test identified nearly 80% of cases. It also distinguished between different types of liver diseases with approximately 85% accuracy.

This development offers a potentially cost-effective and non-invasive tool for early disease detection and monitoring, which could reduce the need for more invasive diagnostic procedures.